With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Anti-Angiogenic (Metronomic) Chemotherapy in Children with Poor Prognosis.||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD||Innovation Grants||2006||Massachusetts|
|Targeting Pediatric Brainstem Glioma with Oncolytic Polioviruses.||Duke University Medical Center / Matthias Gromeier, MD||Innovation Grants||2006||North Carolina|
|HMG-I/Y in pediatric Leukemia and Lymphoma.||The Johns Hopkins University School of Medicine / Linda Smith Resar, MD||Innovation Grants||2006||Maryland|
|Parallel sequencing to identify the causes of childhood cancer.||Baylor College of Medicine / Sharon Plon, MD, PhD||Innovation Grants||2006||Texas|
|Molecular characterization of OTX2 as a novel therapeutic target.||Duke University Medical Center / Hai Yan, MD||Innovation Grants||2006||North Carolina|
|Modeling osteosarcoma to identify novel therapeutic targets.||Stanford University / Julien Sage||Young Investigator Grants||2006||California|
|Tyrosine Kinase Mutation Discovery in Neuroblastoma.||Dana-Farber Cancer Institute / Matthew Meyerson, MD, PhD||Innovation Grants||2006||Massachusetts|
|Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma||Children's Hospital of Philadelphia / Naomi Balamuth, MD||Young Investigator Grants||2006||Pennsylvania|
|Pax3-FKHR targets that enable bypass of cellular senescence in rhabdomyosarcoma.||Duke University Medical Center / Corinne Mary Linardic, MD, PhD||Young Investigator Grants||2006||North Carolina|
|Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture||Children's Hospital Los Angeles / Theresa Harned, MD||Young Investigator Grants||2006||California|